Zeposia
Active Ingredient(s): Ozanimod HydrochlorideFDA Approved: * March 25, 2020
Pharm Company: * CELGENE INTL
Category: Multiple Sclerosis
Ozanimod, sold under the brand name Zeposia, is an immunomodulatory medication for the treatment of relapsing multiple sclerosis and ulcerative colitis.[2][3][4][5] It acts as a sphingosine-1-phosphate (S1P) receptor agonist, sequestering lymphocytes to peripheral lymphoid organs and away from their sites of chronic inflammation.[4] The most common adverse reactions are upper respiratory infection, hepatic transam... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.